Thrombosis Journal

Article	Citations
Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis	62
Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta‐analysis	48
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory	45
Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor	43
Direct oral anticoagulant use in left ventricular thrombus	40
Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity	36
Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis	34
Disseminated intravascular coagulation: new identity as endotheliopathy-associated vascular microthrombotic disease based on in vivo hemostasis and endothelial molecular pathogenesis	32
Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review	29
Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis	28
Viscoelastometry for detecting oral anticoagulants	22
Fatal pulmonary arterial thrombosis in a COVID-19 patient, with asymptomatic history, occurred after swab negativization	22
Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury	22
Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis	21
Coagulopathy associated with COVID-19 – Perspectives & Preventive strategies using a biological response modifier Glucan	20
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19	20
NETosis and SARS-COV-2 infection related thrombosis: a narrative review	20
Current status of treatment of cancer-associated venous thromboembolism	19
High rate of bleeding and arterial thrombosis in COVID-19: Saudi multicenter study	18
Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients	17
A case-report of widespread pulmonary embolism in a middle-aged male seven weeks after asymptomatic suspected COVID 19 infection	16
Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers	15
Switching of vascular cells towards atherogenesis, and other factors contributing to atherosclerosis: a systematic review	15
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials	14
Detailed histological analysis of a thrombectomy-resistant ischemic stroke thrombus: a case report	14

Suspected heparin-induced thrombocytopenia in a COVID-19 patient on extracorporeal membrane oxygenation support: a case report	13
Point-of-care detection and differentiation of anticoagulant therapy - development of thromboelastometry-guided decision-making support algorithms	13
A review of thromboembolic events in hospitalized COVID-19 patients	13
Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review	13
Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis	13
Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intens	13
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis	12
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia	12
Peripherally inserted central venous catheter in upper extremities leads to an increase in D-dimer and deep vein thrombosis in lower extremities	11
ADAMTS13 activity decreases in the early phase of trauma associated with coagulopathy and systemic inflammation: a prospective observational study	11
Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database	11
Predictors of long-term post-thrombotic syndrome following high proximal deep vein thrombosis: a cross-sectional study	11
Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients	11
Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study	11
Factor V Leiden 1691G > A mutation and the risk of recurrent pregnancy loss (RPL): systematic review and meta-analysis	11
Incidence of peripheral intravenous catheter phlebitis and its associated factors among patients admitted to University of Gondar hospital, Northwest Ethiopia: a prospective, observational study	10
D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: a systematic review and metanalysis	10
Safety and efficacy of endovascular thrombectomy in acute ischemic stroke treated with anticoagulants: a systematic review and meta-analysis	10
SARS-CoV-2 and pulmonary embolism: who stole the platelets?	10
Maternal mortality following thromboembolism; incidences and prophylaxis strategies	9
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data	9
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India	9
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism	9
Frequency of deep vein thrombosis at admission for acute stroke and associated factors: a cross-sectional study	9
Incidence and characteristics of arterial thromboemboli in patients with COVID-19	9
Clinical significance of neutrophil extracellular traps biomarkers in thrombosis	9
GST null polymorphisms may affect the risk of coronary artery disease: evidence from a meta-analysis	9
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in Thailand	8
Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients	8
Von Willebrand factor:antigen and ADAMTS-13 level, but not soluble P-selectin, are risk factors for the first asymptomatic deep vein thrombosis in cancer patients undergoing chemotherapy	8
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study	8
Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study	8
Platelet adhesion in type 2 diabetes: impact of plasma albumin and mean platelet volume	8
Lupus anticoagulant hypoprothrombinemia syndrome associated with bilateral adrenal haemorrhage in a child: early diagnosis and intervention	8
Review article inferior vena cava thrombosis: a case series of patients observed in Taiwan and literature review	8
Prognostic Value of D-dimer in patients with acute coronary syndrome treated by percutaneous coronary intervention: a retrospective cohort study	8
Postpartum vertebral artery dissection: case report and review of the literature	8
Current and future strategies to monitor and manage coagulation in ECMO patients	8
Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore	8
Malignant tumor is the greatest risk factor for pulmonary embolism in hospitalized patients: a single-center study	7
Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis	7
Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study	7
The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients	7
Correction to: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis	7
Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer	7
Use of laboratory testing for prediction of postoperative bleeding volume in cardiovascular surgery	7
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia	7
Thrombosis management in times of COVID-19 epidemy; a Dutch perspective	7
The predictive value of D-dimer test for venous thromboembolism during puerperium in women age 35 or older: a prospective cohort study	6
Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry	6

The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study	6
Comparison of deep vein thrombosis risks in acute respiratory distress syndrome caused by COVID-19 and bacterial pneumonia: a retrospective cohort study	6
Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report	6
Endovascular revascularization strategies using catheter-based thrombectomy versus conventional catheter-directed thrombolysis for acute limb ischemia	6
Agitation-dependent biomechanical forces modulate GPVI receptor expression and platelet adhesion capacity during storage	6
Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis	6
Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia	6
Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated w	6
Collagen-dependent platelet dysfunction and its relevance to either mitochondrial ROS or cytosolic superoxide generation: a question about the quality and functional competence of long-stored platelet	6
Calibrated automated thrombogram II: removing barriers for thrombin generation measurements	6
JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature	5
Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study	5
Coagulopathy and its associated factors among patients with a bleeding diathesis at the University of Gondar Specialized Referral Hospital, Northwest Ethiopia	5
Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System	5
Long noncoding RNA TUG1 induces angiogenesis of endothelial progenitor cells and dissolution of deep vein thrombosis	5
Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients	5
Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study	5
Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency	5
An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study	5
Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis	5
The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines	5
A modified microchip-based flow chamber system for evaluating thrombogenicity in patients with thrombocytopenia	5
Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study	5
Therapeutic duplication of anticoagulants: a retrospective study of frequency and consequences in a tertiary referral hospital	5
Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT	5
Feasibility of anticoagulation using low molecular-weight heparin during catheter-directed thrombolysis for lower extremity deep venous thrombosis	5
Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors	5
Anticoagulation may contribute to antimicrobial treatment of Lemierre syndrome: a case report	4
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19	4
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications	4
Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?	4
Lead thrombus under standard-dose edoxaban in a patient with normal to high creatinine clearance and protein S deficiency	4
Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review	4
Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity	4
Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis	4
The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country	4
The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China	4
The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study	4
Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging	4
Enoxaparin-induced reactive thrombocytosis: a case report	4
Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study	4
Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study	4
LINC00659 exacerbates endothelial progenitor cell dysfunction in deep vein thrombosis of the lower extremities by activating DNMT3A-mediated FGF1 promoter methylation	4
Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus 2	4
Clinical significance of D-dimer levels during acute period in ischemic stroke	4
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE	4
High prevalence of thrombophilic risk factors in patients with central retinal artery occlusion	4
Giant intracardiac thrombosis in an infant with leukaemia and prolonged COVID-19 viral RNA shedding: a case report	4
Comparison of anticoagulated versus non-anticoagulated patients with intra-aortic balloon pumps	4
COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab	4
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis	4
Unprovoked internal jugular vein thrombosis: a case report and literature review	4
Association between cardiovascular risk-factors and venous thromboembolism in a large longitudinal study of French women	3
Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis	3
Monitoring coagulation-fibrinolysis activation prompted timely diagnosis of hemophagocytic lymphohistiocytosis-related disseminated intravascular coagulation	3
Damage-associated molecular patterns and fibrinolysis perturbation are associated with lethal outcomes in traumatic injury	3
Blue toe syndrome caused by emboli from anomalous left atrial septal pouch thrombus: a case report	3
Tranexamic acid alters the immunophenotype of phagocytes after lower limb surgery	3
Modified thromboelastometric tests provide improved sensitivity and specificity to direct oral anticoagulants compared to standard thromboelastometric tests in-vitro	3
Anti-inflammatory and antioxidant efficacy of lavender oil in experimentally induced thrombosis	3
A case-report of the unprovoked thrombotic event in a patient with thymoma and severe FVII deficiency	3
Superior vena cava thrombosis and dilated cardiomyopathy as initial presentations of Behcet’s disease	3
The role of Sphingomyelin synthase 2 (SMS2) in platelet activation and its clinical significance	3
Serum interleukin 1β and sP-selectin as biomarkers of inflammation and thrombosis, could they be predictors of disease severity in COVID 19 Egyptian patients? (a cross-sectional study)	3
The efficacy of tranexamic acid treatment with different time and doses for traumatic brain injury: a systematic review and meta-analysis	3
Multiple simultaneous embolic cerebral infarctions 11 months after COVID-19	3
A cross-sectional, multicenter, observational study to assess the prophylaxis of venous thromboembolism in Lebanese and Jordanian hospitals	3
Combined thrombogenic effects of vessel injury, pregnancy and procoagulant immune globulin administration in mice	3
Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation	3
Nonnegligible causes of symptoms of acute lower extremities——3 cases of May-Thurner syndrome with deep vein thrombosis	3
Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review	3
Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiecta	3
The association of alcohol with circulating total fibrinogen and plasma clot density is mediated by fibrinogen and FXIII genotypes	3
Hospitalized patients with isolated distal deep vein thrombosis: anticoagulation therapy or not?	3
Platelet indices and blood pressure: a multivariable mendelian randomization study	3
Prognostic value of plasma high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study	3
Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study	2
Fibrinolytic markers could be useful predictors of severity in patients with pulmonary arterial hypertension: a retrospective study	2
The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review	2
Narsoplimab for severe transplant-associated thrombotic microangiopathy	2

LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study	2
The risk for post-thrombotic syndrome of subjects with deep vein thrombosis in an Indonesian referral hospital: a retrospective cohort study	2
Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer	2
An evaluation of circulating activated TAFI in septic DIC: a case series and review of the literature	2
Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome	2
A prediction nomogram for deep venous thrombosis risk in patients undergoing primary total hip and knee arthroplasty: a retrospective study	2
Prevalence and risk factor of post-operative lower extremities deep vein thrombosis in patients undergoing gynecologic surgery: a single-institute cross-sectional study	2
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma	2
Prevalence of venous obstructions in (recurrent) venous thromboembolism: a case-control study	2
Aspirin and clopidogrel resistance; a neglected gap in stroke and cardiovascular practice in Iran: a systematic review and meta-analysis	2
Prevalence, risk, and outcome of deep vein thrombosis in acute respiratory distress syndrome	2
Incidence of proximal deep vein thrombosis in medical critical care patients	2
Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial	2
Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study	2
Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background	2
A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism	2
Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis	2
Very severe immune thrombocytopenia following SARS-CoV-2 vaccination requiring splenectomy: a case report	2
Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation	2
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article	2
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais	2
Effects of concomitant use of prasugrel with edoxaban on bleeding time, pharmacodynamics, and pharmacokinetics of edoxaban in healthy elderly Japanese male subjects: a clinical pharmacology study	2
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system	2
Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis	2
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time	2
Risk factors for central venous catheter-associated deep venous thrombosis in pediatric critical care settings identified by fusion model	2
Long non-coding RNA crnde promotes deep vein thrombosis by sequestering miR-181a-5p away from thrombogenic Pcyox1l	2
Sex-specific associations between systolic, diastolic and pulse pressure and hemostatic parameters in the population-based KORA-Fit study: a cross-sectional study	2
Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy	2
Increased dose primary thromboprophylaxis in ambulatory patients with advanced pancreatic ductal adenocarcinoma, a single centre cohort study	2
Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis	2
Superior vena cava syndrome after pacemaker implantation treated with direct oral anticoagulation	2
How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation	2
Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases	2
Application and risk prediction of thrombolytic therapy in cardio-cerebrovascular diseases: a review	2
A thrombophilia family with protein S deficiency due to protein translation disorders caused by a Leu607Ser heterozygous mutation in PROS1	2
Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction	2
Circulating LPS from gut microbiota leverages stenosis-induced deep vein thrombosis in mice	2
Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial	2
Coexistence of antithrombin deficiency and suspected inferior vena cava atresia in an adolescent and his mother – case report and clinical implications	2
Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how	2